Table 1 Vaccination scenarios to be examined using the dynamic model
Scenarios 1 and 2 | Scenarios 3 and 4 | Scenarios 5 and 6 | |
|---|---|---|---|
Pandemic transmissibility* | Mild/Severe | Mild/Severe | Mild/Severe |
Season of emergence | Spring/Fall | Spring/Fall | Spring/Fall |
Level of pre-existing immunity in level of pre-existing immunity in population | 0% | 0% | 0% |
Time at which first vaccine becomes available (range) | 6 months | 1 month (1–3 months) | 1 month (1–3 months) |
Time at which additional vaccine becomes available | _ | _ | 6 months |
Doses of traditional (egg-based) vaccine required | 1/2 | _ | 1/2 |
Doses of novel (plant-based) vaccine required | _ | 1/2 | 1/2 |
Vaccine coverage* | UIIP | UIIP | UIIP |
Vaccine production for traditional vaccine | 3.75 M doses/week | 3.75 M doses/week | |
Vaccine production for novel vaccine | 150,000 doses/week1.5 M doses/week | 150,000 doses/week1.5 M doses/week | |
Outcomes** | CPIP moderate | CPIP moderate | CPIP moderate |